Annual and Special Reporting by the Firm
Auditor Reporting of Certain Audit Participants
Form | Filed Date | Issuer Name | Audit Report Date | Engagement Partner | |
Form AP
|
04/19/2024
|
Galapagos NV
|
03/23/2023
|
Houthaeve, Nico Marc
|
|
Form AP
|
03/29/2024
|
iTeos Therapeutics, Inc.
|
03/06/2024
|
Neijens, Koen
|
|
Form AP
|
04/14/2023
|
Galapagos NV
|
03/23/2023
|
Houthaeve, Nico Marc
|
|
Form AP
|
04/11/2023
|
iTeos Therapeutics, Inc.
|
03/15/2023
|
Neijens, Koen
|
|
Form AP
|
04/21/2022
|
iTeos Therapeutics, Inc.
|
03/23/2022
|
Neijens, Koen
|
|
Form AP
|
04/21/2022
|
Galapagos NV
|
03/24/2022
|
Houthaeve, Nico Marc
|
|
Form AP
|
04/20/2021
|
Galapagos NV
|
03/25/2021
|
Houthaeve, Nico Marc
|
|
Form AP
|
04/14/2021
|
iTeos Therapeutics, Inc.
|
03/24/2021
|
Neijens, Koen
|
|
Form AP
|
07/28/2020
|
iTeos Therapeutics, Inc.
|
05/22/2020
|
Neijens, Koen
|
|
Form AP
|
07/02/2020
|
iTeos Therapeutics, Inc.
|
05/22/2020
|
Neijens, Koen
|
|
Form AP
|
04/23/2020
|
Galapagos NV
|
03/27/2020
|
Vanhees, Gert Bert A
|
|
Form AP
|
04/23/2020
|
Anheuser-Busch InBev SA/NV
|
03/13/2019
|
Brehmen, Joël Paul E
|
|
Form AP
|
05/02/2019
|
Galapagos NV
|
03/29/2019
|
Vanhees, Gert Bert A
|
|
Form AP
|
04/25/2019
|
Anheuser-Busch InBev SA/NV
|
03/13/2019
|
Brehmen, Joël Paul E
|
|
Form AP
|
04/24/2018
|
Galapagos NV
|
03/22/2018
|
Vanhees, Gert Bert A
|
|
Form AP
|
04/24/2018
|
Ablynx NV
|
03/26/2018
|
Houthaeve, Nico Marc
|
|
Form AP
|
04/22/2018
|
Anheuser-Busch InBev SA/NV
|
03/15/2018
|
Brehmen, Joël Paul E
|
|
Form AP
|
10/10/2017
|
Ablynx NV
|
07/25/2017
|
Houthaeve, Nico Marc
|
|
Form AP
|
04/10/2017
|
Anheuser-Busch InBev SA/NV
|
03/22/2017
|
Brehmen, Joël Paul E
|
|
Form AP
|
04/10/2017
|
Galapagos NV
|
03/21/2017
|
Vanhees, Gert Bert A
|
|
|
Currently Subject to Board Determination Under the Holding Foreign Companies Accountable Act?
|